Category: Pharmaceuticals
Pharmaceuticals market research reports by GlobalData
-
Canada General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030
Canada General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030 Summary GlobalData’s “Canada General Surgery Device Procedures Outlook to 2030” is a ... Read More
-
Russia General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030
Russia General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030 Summary GlobalData’s “Russia General Surgery Device Procedures Outlook to 2030” is a ... Read More
-
Japan Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
Japan Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summary ... Read More
-
Mexico Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
Mexico Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More
-
Brazil Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
Brazil Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More
-
United Kingdom (UK) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to trea
United Kingdom (UK) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast t ... Read More
-
North America Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uter
North America Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 ... Read More
-
Asia-Pacific (APAC) Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030
Asia-Pacific (APAC) Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030 Summary GlobalData’s “Asia-Pacific Reconstruction Meshes Procedu ... Read More
-
North America Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030
North America Reconstruction Meshes Procedures Count by Segments (Breast Reconstruction Procedures using Meshes, Pelvic Organ Prolapse Procedures using Meshes and Urinary Incontinence Procedures using Slings) and Forecast to 2030 Summary GlobalData’s “North America Reconstruction Meshes Procedures O ... Read More
-
Melanoma Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031
Melanoma Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for markete ... Read More
-
Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031
Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for m ... Read More
-
ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review
ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an ... Read More
-
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in BDD therapeutics. There will be 67,698,071 total prevalent cases of BDD in 2023 in ... Read More
-
Duchenne Muscular Dystrophy Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Duchenne Muscular Dystrophy Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2023 provides an overview of Duche ... Read More
-
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis - Global Clinical Trials Review, 2023 provides an overview of A ... Read More
-
Cardiovascular Imaging Equipment Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Cardiovascular Imaging Equipment Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Cardiovascular Imaging Equipment Pipeline Report including Stages of Development, Segm ... Read More
-
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Tria ... Read More
-
Inflammatory Bowel Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Inflammatory Bowel Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Inflammatory Bowel Disease - Global Clinical Trials Review, 2023 provides an overview of Inflamm ... Read More
-
Actelion Pharmaceuticals Ltd - Strategic SWOT Analysis Review
Actelion Pharmaceuticals Ltd - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod ... Read More
-
Bone Grafts and Substitutes Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033
Bone Grafts and Substitutes Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033 Summary Bone Grafts and Substitutes Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulato ... Read More
-
Ankylosing Spondylitis (Bekhterev's Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Ankylosing Spondylitis (Bekhterev's Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, ... Read More
-
Spondyloarthritis (Spondyloarthropathy) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Spondyloarthritis (Spondyloarthropathy) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Spondyloarthritis (Spondyloarthropathy) - Global Clinical Trials Review, 2023 provi ... Read More
-
Obsessive-Compulsive Disorder Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Obsessive-Compulsive Disorder Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2023 provides an overview of O ... Read More
-
Diffuse Large B-Cell Lymphoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Diffuse Large B-Cell Lymphoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma - Global Clinical Trials Review, 2023 provides an overview of D ... Read More
-
Carotid and Renal Artery Stents Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033
Carotid and Renal Artery Stents Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033 Summary Carotid and Renal Artery Stents Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, ... Read More
Research Assistance
